NovaBridge Biosciences Share-based Payment Arrangement, Expense
NovaBridge Biosciences (NBP) reported Share-based Payment Arrangement, Expense of $400.00 thousand for the 6-month period ending 2025-06-30, per its 6-K filed 2025-10-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2025-10-06
- NovaBridge Biosciences share-based payment arrangement, expense for the quarter ending 2020-12-31 was 133.59M CNY, a 1335850.00% increase year-over-year.
- NovaBridge Biosciences share-based payment arrangement, expense for the quarter ending 2019-12-31 was 10.00K CNY.
CNY
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2023-12-31 | 197.82M CNY 20-F · filed 2024-04-30 | |||
| 2022-12-31 | 371.00M CNY 20-F · filed 2024-04-30 | |||
| 2022-06-30 | 198.87M CNY 6-K · filed 2022-11-10 | |||
| 2021-12-31 | 621.88M CNY 20-F · filed 2024-04-30 | |||
| 2021-06-30 | 347.06M CNY 6-K · filed 2022-11-10 | |||
| 2020-12-31 | 133.59M CNY derived: 20-F 12 month − 6-K 9 month · filed 2023-05-01 | 526.17M CNY 20-F · filed 2023-05-01 | ||
| 2020-09-30 | 392.58M CNY 6-K · filed 2021-02-05 | |||
| 2019-12-31 | 10.00K CNY derived: 20-F 12 month − 6-K 9 month · filed 2022-04-29 | 515.20M CNY 20-F · filed 2022-04-29 | ||
| 2019-09-30 | 515.19M CNY 6-K · filed 2021-02-05 | |||
| 2018-12-31 | 3.52M CNY 20-F · filed 2021-04-28 |
USD
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2025-06-30 | $400.00K 6-K · filed 2025-10-06 | ||||
| 2024-12-31 | $1.50M 20-F · filed 2025-04-03 | ||||
| 2024-06-30 | -$2.30M 6-K · filed 2025-10-06 | ||||
| 2023-12-31 | $5.10M 20-F · filed 2025-04-03 | $27.86M 20-F · filed 2024-04-30 | |||
| 2022-12-31 | $6.80M 20-F · filed 2025-04-03 | $53.79M 20-F · filed 2023-05-01 | |||
| 2022-06-30 | $30.57M 6-K · filed 2022-11-10 | ||||
| 2021-12-31 | $97.59M 20-F · filed 2022-04-29 | ||||
| 2020-12-31 | $22.82M derived: 20-F 12 month − 6-K 9 month · filed 2021-04-28 | $80.64M 20-F · filed 2021-04-28 | |||
| 2020-09-30 | $57.82M 6-K · filed 2021-02-05 | ||||
| 2019-12-31 | $0.00 20-F · filed 2021-04-28 | ||||
| 2018-12-31 | $0.00 20-F · filed 2021-04-28 |